Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DUAL I: IDegLira vs Insulin Degludec or Liraglutide in Type 2 Diabetes
NCT01336023Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- May 2011
- Primary completion
- May 2012
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 20
01
Overview
A Phase 3 trial of insulin degludec + liraglutide in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started May 2011; status: completed.
02
Drugs
insulin degludec + liraglutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01336023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01336023.